Trial reportBMC ophthalmology2025
Shortening surgical time in high myopia treatment: a randomized controlled trial comparing non-OVD and OVD techniques in ICL implantation.
Trial report in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intraoperative Hemorrhage during Implantable Collamer Lens Surgery: A Case Report and Management Strategy.Case reports in ophthalmologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionHigh myopia correction is essential for improving visual acuity and quality of life. Traditional intraocular collamer lens (ICL) implantation using an ophthalmic viscosurgical device (OVD) is effective but often results in prolonged surgical times, impacting patient comfort and recovery. This study investigates a novel non-OVD ICL implantation technique aimed at reducing surgical duration and improving patient outcomes.
methodsThis prospective, randomized controlled trial was conducted at Changsha Aier Eye Hospital from May to August 2024, enrolling 162 right eyes from high myopic patients aged 21 to 45 years. Participants were randomly assigned to either the non-OVD group, which utilized a disposable sterile irrigator for anterior chamber maintenance, or the OVD group, which underwent traditional ICL implantation. Primary outcomes included surgical time, endothelial cell density (ECD), intraocular pressure (IOP), and patient-reported experiences.
resultsThe non-OVD group demonstrated a significant reduction in surgical time (113 ± 103 s) compared to the OVD group (436 ± 118 s, p < 0.001). ECD and IOP remained stable postoperatively, indicating no adverse effects on ocular health. Patient experiences were assessed through pain levels and self-perception reports; the non-OVD group reported comparable pain levels with enhanced self-perception compared to the OVD group.
conclusionThe novel non-OVD ICL implantation technique significantly reduces surgical duration while maintaining ocular health and improving patient self-perception. Additional to it, we also explored patients' self-perception, which refers to their subjective evaluation of recovery, well-being, and visual outcomes post-surgery. Unlike satisfaction, which primarily measures how pleased patients are with the results, self-perception encompasses how patients feel about their overall recovery process, including psychological and emotional factors. This approach may enhance operational efficiency and patient comfort in high myopia surgeries.
trial registrationThe study was registered with the China Clinical Trial Registration Center (Registration No. ChiCTR2100046483, Trial Registration: 2021-03-06).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.